Indianapolis, INNCT06901531Now EnrollingIRB Ready

Gastric Cancer Clinical Trial in Indianapolis, IN

Access cutting-edge gastric cancer treatment through this clinical trial at a research site in Indianapolis. Study-provided care at no cost to qualified participants.

Sponsored by Astellas Pharma Global Development, Inc.

Quick Self-Assessment

See if you qualify for this Indianapolis location

Preparing your pre-screening questions...

Expert Care in Indianapolis

Access gastric cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related gastric cancer treatment provided free

Apply for This Indianapolis Location

Check if you qualify for this gastric cancer clinical trial in Indianapolis, IN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Indianapolis

    Convenient for IN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Indianapolis site if eligible
  4. 4Begin participation

About This Gastric Cancer Study in Indianapolis

Zolbetuximab is being studied in people with cancer in and around the stomach or where the food pipe (esophagus) joins the stomach, called gastroesophageal junction (GEJ) cancer. Zolbetuximab with chemotherapy may be used to treat stomach and GEJ cancer when the cancer cells do not have a protein called HER2 (human epidermal growth factor receptor 2) on their surface (HER2-negative) but do have a protein called Claudin 18.2 (Claudin 18.2-positive). Zolbetuximab is thought to work by attaching to

Sponsor: Astellas Pharma Global Development, Inc.

Who Can Participate

Inclusion Criteria

Participant has histologically confirmed gastric or Gastroesophageal Junction (GEJ) adenocarcinoma.
Participant has radiographically confirmed, locally advanced, unresectable or metastatic disease within 28 days prior to randomization.
Participant has radiologically evaluable disease (measurable and/or nonmeasurable) according to Response Evaluation Criteria in Solid Tumors (RECIST) V1.1, ≤ 28 days prior to randomization. For participants with only 1 evaluable lesion and prior radiotherapy ≤ 3 months before randomization, the lesion must either be outside the field of prior radiotherapy or have documented progression following radiation therapy.
Participant has Eastern Cooperative Oncology Group Performance Status (ECOG) performance status 0 to 1.
Participant has predicted life expectancy ≥ 12 weeks.
Participant must be a candidate to receive mFOLFOX6 or CAPOX and pembrolizumab.
Female participant is not pregnant and at least 1 of the following condit

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Indianapolis?

Yes, this clinical trial (NCT06901531) has an active research site in Indianapolis, IN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Gastric Cancer Treatment Options in Indianapolis, IN

If you're searching for gastric cancer treatment options in Indianapolis, IN, this clinical trial (NCT06901531) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Indianapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced gastric cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all gastric cancer clinical trials near you to find additional studies recruiting in your area.

More Stomach Cancer Trials in Indianapolis, IN

See all stomach cancer clinical trials recruiting in Indianapolis — not just this study.

Browse Stomach Cancer Trials in Indianapolis

Ready to Join in Indianapolis?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Indianapolis, IN